Analysts expect Organon to report an earnings per share (EPS) of $0.72.
Organon bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.09, leading to a 2.46% drop in the share price on the subsequent day.
Here's a look at Organon's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.92
0.92
0.89
0.87
EPS Actual
1.01
1.00
1.02
0.90
Price Change %
-2.00
4.00
1.00
-6.00
Stock Performance
Shares of Organon were trading at $7.81 as of February 10. Over the last 52-week period, shares are down 52.82%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Insights Shared by Analysts on Organon
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Organon.
Analysts have provided Organon with 1 ratings, resulting in a consensus rating of Underperform. The ...
